Tumour treatment among all phase 1a cohorts in were concluded with no safety concerns
News
Celadon secures medicinal cannabis contract
Celadon will sell a minimum of £3m worth of the high-THC product over the next three years
AstraZeneca provide further Breztri evidence
Vital data supports early intervention in order to treat chronic obstructive pulmonary disease
Scarlet Therapeutics gains funding for blood cell platform
Vital financing will allow the company to build a pipeline of novel therapies targeting serious conditions
Positive data for AnaMar’s fibrosis therapy
Receptor antagonist AM1476 developed as an anti-fibrotic treatment for lung and skin disorders
Eisai makes lecanemab therapy application
Treatment involves early Alzheimer’s disease and will be potentially used across Great Britain
Vital patent for AlzeCure Alzheimer’s drug
ACD856 is the leading candidate therapy on the company’s NeuroRestore platform
AstraZeneca’s dapagliflozin recommended by NICE
Treatment concerns up to 150,000 patients in England with chronic heart failure
NICE nod for Genedrive’s CYP2C19 candidate
Screening patients to assess their clopidogrel resistance status will allow for alternative treatments
Debiopharm commences pivotal glioblastoma therapy study
The therapy is a brain-penetrant used in various combinations in patients with progressive glioblastoma
NICE recommendation for AbbVie’s Rinvoq
The approved drug has been developed to treat patients with moderate to severe Crohn’s disease
Pharmanovia and Closed Loop Medicine in precision medicine partnership
Dosing optimisation technology will be incorporated alongside anti-hypertensive drugs
FIND and VIA Global Health expand access to diagnostics
Partnership will provide a healthcare boost across in low and middle-income countries
Robotic platform R-One+ launched by Robocath
Solution allows a cardiologist to perform coronary angioplasties using an integrated control command unit
Approval provided for Angelini’s cenobamate
Treatment will now be used across Ireland among adults with focal onset seizures with epilepsy
